Cystic fibrosis in adults

On this page

Pathophysiology & Genetics - Salty Sweat & Sticky Stuff

  • Genetics: Autosomal recessive mutation in the CFTR gene on chromosome 7.
    • Most common mutation: ΔF508, a Class II mutation leading to misfolded protein.
  • Pathophysiology: A defective CFTR protein creates a dysfunctional chloride channel, disrupting ion transport across epithelial cells.

Cystic Fibrosis: Multi-organ Manifestations

  • Mechanism & Effect:
    • Sweat Ducts: Impaired NaCl reabsorption → high salt content in sweat (diagnostic).
    • Airways/Pancreas: Decreased Cl⁻ secretion → thick, dehydrated mucus → obstruction, infection, and inflammation.

⭐ The "salty sweat" paradox: In sweat glands, CFTR reabsorbs chloride. In respiratory/GI epithelia, it secretes chloride. The channel's function is tissue-specific.

Clinical Manifestations - The Multi-System Mayhem

Cystic Fibrosis: Multi-Organ System Effects and Genetics

  • Pulmonary: The dominant cause of morbidity/mortality.
    • Persistent productive cough, wheezing, recurrent sinus/pulmonary infections (esp. Pseudomonas aeruginosa, S. aureus).
    • Leads to bronchiectasis, hemoptysis, and eventual respiratory failure.
  • Gastrointestinal:
    • Exocrine pancreatic insufficiency (~85%): Steatorrhea, malabsorption of vitamins A, D, E, K.
    • Distal Intestinal Obstruction Syndrome (DIOS).
  • Hepatobiliary: Focal biliary cirrhosis, cholestasis, portal hypertension.
  • Endocrine: CF-Related Diabetes (CFRD) due to progressive pancreatic islet destruction.
  • Reproductive:
    • Males: Infertility (>95%) from congenital bilateral absence of the vas deferens (CBAVD).
    • Females: Reduced fertility (thick, tenacious cervical mucus).
  • Other: Digital clubbing, hypertrophic osteoarthropathy, high sweat chloride.

⭐ Recurrent pulmonary exacerbations, often with mucoid Pseudomonas aeruginosa, are a hallmark of adult CF, strongly linked to accelerated decline in lung function.

Diagnosis - Catching the Chloride Culprit

  • Primary Test: Quantitative pilocarpine iontophoresis (Sweat Chloride Test).
  • Thresholds (mmol/L):
    • < 30: CF unlikely.
    • 30-59: Intermediate; requires further testing.
    • ≥ 60: Diagnostic.
  • Genetic Confirmation: CFTR gene analysis for inconclusive sweat tests or atypical presentations.

⭐ A diagnosis of CF generally requires clinical symptoms plus evidence of CFTR dysfunction (e.g., two positive sweat tests on different days, or identifying two CF-causing mutations).

Management & Treatment - The Modulator & Mop-Up Crew

  • CFTR Modulators: Cornerstone therapy based on genotype.
    • Potentiators (e.g., Ivacaftor): Increase channel opening for gating mutations (e.g., G551D).
    • Correctors (e.g., Lumacaftor, Tezacaftor): Improve protein folding/trafficking for processing mutations (e.g., F508del).
    • Combination (e.g., Elexacaftor/Tezacaftor/Ivacaftor - Trikafta): Highly effective for patients with at least one F508del mutation.
  • Airway Clearance ("Mop-Up"):
    • Dornase alfa (DNase) & hypertonic saline.
    • Chest physiotherapy (vest, percussion).
  • Chronic Therapies:
    • Inhaled antibiotics for Pseudomonas (e.g., tobramycin, aztreonam).

⭐ Chronic azithromycin use is primarily for its anti-inflammatory and biofilm-disrupting effects, not its direct bactericidal action.

High‑Yield Points - ⚡ Biggest Takeaways

  • Autosomal recessive CFTR gene mutation (ΔF508 is most common) causes defective chloride transport across epithelial cells.
  • Suspect in adults with recurrent sinopulmonary infections (especially Pseudomonas), pancreatic insufficiency, and male infertility.
  • Diagnosis is confirmed by an elevated sweat chloride test > 60 mEq/L.
  • Pulmonary disease manifests as obstructive PFTs and bronchiectasis, the primary cause of mortality.
  • Management includes airway clearance, pancreatic enzyme replacement, and antibiotics.
  • CFTR modulators are a key emerging therapy.

Practice Questions: Cystic fibrosis in adults

Test your understanding with these related questions

A 4-year-old boy is brought by his parents to his pediatrician’s office. His mother mentions that the child has been producing an increased number of foul stools recently. His mother says that over the past year, he has had 1 or 2 foul-smelling stools per month. Lately, however, the stools are looser, more frequent, and have a distinct odor. Over the past several years, he has been admitted 4 times with episodes of pneumonia. Genetic studies reveal a mutation on a specific chromosome that has led to a 3 base-pair deletion for the amino acid phenylalanine. Which of the following chromosomes is the defective gene responsible for this boy’s clinical condition?

1 of 5

Flashcards: Cystic fibrosis in adults

1/6

How does cystic fibrosis affect K+ levels? _____

TAP TO REVEAL ANSWER

How does cystic fibrosis affect K+ levels? _____

Decreased (hypokalemia)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial